Screening of anti‐thrombin active components from Ligusticum chuanxiong by affinity‐ultrafiltration coupled with HPLC‐Q‐Orbitrap‐MSn

Abstract

AbstractIntroductionLigusticum chuanxiong (‘chuanxiong’) is a traditional Chinese medicine for promoting blood circulation and removing blood stasis, which is often used to treat thrombotic diseases. However, its potential anticoagulant active ingredients have been unexplored.ObjectivesThe study aims to establish an affinity ultrafiltration mass spectrometry (AUF‐MS) method for rapid screening of anti‐thrombin active components of chuanxiong and to verify it in vitro.MethodIn this study, the chemical constituents of different parts of chuanxiong were determined. A method for rapid screening of anticoagulant active ingredients by AUF‐MS was established using thrombin as an affinity receptor target. Subsequently, the anticoagulant effect of such ligands was verified by in vitro anticoagulation experiments such as chromogenic substrate method and in vitro coagulation assay. Then the possible interaction mechanism between these ligands and thrombin was further studied by molecular docking.ResultsTwenty‐one components were detected from different parts of chuanxiong. And three potential anti‐thrombin active components were screened: ferulic acid, chlorogenic acid, isochlorogenic acid A by AUF coupled with high‐performance liquid chromatography‐quadrupole‐Orbitrap mass spectrometry (HPLC‐Q‐Orbitrap‐MSn). The in vitro activity experiments and molecular docking revealed that these potential ligands exhibited strong binding ability and inhibitory activities on thrombin.ConclusionThe present study revealed that chuanxiong is a traditional Chinese medicine with excellent anticoagulation effects. Meanwhile, the integrated strategy based on AUF‐MS, in vitro experiments and molecular docking also provided a powerful tool for further exploration of active ingredients responsible for the anticoagulant activity in chuanxiong.